To Evaluate the Phase I Clinical Study of XZB-0004 in Patients With AML and MDS
NCT05740917
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
82
Enrollment
INDUSTRY
Sponsor class
Conditions
AML
MDS
Interventions
DRUG:
XZB-0004
Sponsor
Xuanzhu Biopharmaceutical Co., Ltd.